Moreover, several studies have recently reported that the AKT/PKB signaling pathway is involved in cell survival in various cancers such as colon carcinoma, glioma, melanoma, breast and liver carcinoma due to the abnormal activation of the downstream gene AKT [24–26]. This evidence concerns the gene AKT1 and central nervous system cancer.